tiprankstipranks
Trending News
More News >
Bastei Luebbe (DE:BST)
:BST
Advertisement

Bastei Luebbe (BST) AI Stock Analysis

Compare
3 Followers

Top Page

DE

Bastei Luebbe

(LSE:BST)

Rating:74Outperform
Price Target:
Bastei Luebbe's strong financial performance and positive price trends highlight its growth potential. However, challenges in cash flow management and moderate valuation metrics slightly temper the overall outlook. The focus on improving liquidity could enhance future prospects.

Bastei Luebbe (BST) vs. iShares MSCI Germany ETF (EWG)

Bastei Luebbe Business Overview & Revenue Model

Company DescriptionBastei Luebbe (BST) is a prominent German publishing company that operates in the media sector, focusing on the production and distribution of books, audiobooks, and digital content. The company is one of Germany's largest independent publishers, offering a wide array of genres including fiction, non-fiction, children's literature, and entertainment. Bastei Luebbe is known for its strong portfolio of popular authors and its commitment to delivering high-quality content across various formats.
How the Company Makes MoneyBastei Luebbe generates revenue primarily through the sale of its published content. The company's key revenue streams include the sale of physical books through retail and online channels, digital content such as e-books and audiobooks, and licensing deals for adaptation into other media forms like films and television series. Additionally, Bastei Luebbe benefits from partnerships with authors and media companies, allowing it to expand its reach and distribution capabilities. The company's strategic focus on both traditional and digital platforms enables it to cater to a broad audience while adapting to changing consumer preferences in the publishing industry.

Bastei Luebbe Financial Statement Overview

Summary
Bastei Luebbe shows strong revenue growth and profitability with a robust balance sheet, characterized by low leverage and strong equity. However, cash flow management indicates some liquidity constraints, needing improvement to support growth.
Income Statement
85
Very Positive
Bastei Luebbe has demonstrated strong revenue growth with a 10.3% increase from the previous year. The gross profit margin stands at 50.3%, indicating efficient cost management. The net profit margin improved significantly to 7.9% from 3.9%, showcasing enhanced profitability. EBIT and EBITDA margins are healthy, at 11.5% and 14.1% respectively, reflecting operational efficiency. Overall, the income statement reveals a trajectory of growth and profitability.
Balance Sheet
78
Positive
The balance sheet shows a solid equity base with an equity ratio of 59.0%, indicating a stable financial foundation. The debt-to-equity ratio is low at 0.13, suggesting manageable leverage levels. Return on equity is strong at 14.2%, highlighting effective utilization of shareholder funds. The company maintains a healthy level of cash and equivalents, supporting financial stability. Overall, the balance sheet reflects a well-managed financial position with potential for growth.
Cash Flow
68
Positive
Free cash flow decreased by 82.9% year-over-year, primarily due to a decline in operating cash flow. The operating cash flow to net income ratio is 0.30, indicating moderate cash generation from operations. However, the free cash flow to net income ratio is 0.19, which suggests potential constraints in liquidity management. Despite these challenges, the company remains capable of covering its capital expenditures through its cash flows. Overall, cash flow management shows room for improvement.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue113.91M110.33M100.02M94.51M92.69M81.48M
Gross Profit45.35M55.45M50.52M49.02M44.85M36.44M
EBITDA18.20M15.60M10.20M17.53M13.73M6.54M
Net Income9.81M8.72M3.92M10.96M7.50M-6.12M
Balance Sheet
Total Assets107.16M103.94M107.91M104.29M90.14M68.58M
Cash, Cash Equivalents and Short-Term Investments20.95M18.39M19.62M18.18M14.66M3.15M
Total Debt10.40M8.25M9.66M11.50M13.23M10.53M
Total Liabilities43.49M42.38M52.92M48.00M47.51M41.23M
Stockholders Equity63.43M61.34M54.78M56.09M42.52M28.30M
Cash Flow
Free Cash Flow4.41M1.63M9.55M12.30M15.53M9.28M
Operating Cash Flow4.41M2.66M10.42M12.85M16.88M14.27M
Investing Cash Flow0.001.55M-761.00K-2.78M-5.33M-2.54M
Financing Cash Flow0.00-5.27M-8.18M-6.63M16.00K-12.13M

Bastei Luebbe Technical Analysis

Technical Analysis Sentiment
Positive
Last Price10.05
Price Trends
50DMA
10.14
Negative
100DMA
10.47
Negative
200DMA
10.00
Positive
Market Momentum
MACD
-0.02
Negative
RSI
53.98
Neutral
STOCH
60.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:BST, the sentiment is Positive. The current price of 10.05 is above the 20-day moving average (MA) of 9.92, below the 50-day MA of 10.14, and above the 200-day MA of 10.00, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 53.98 is Neutral, neither overbought nor oversold. The STOCH value of 60.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:BST.

Bastei Luebbe Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
€47.68B5.055.52%7.06%1.62%-38.38%
DEBST
74
Outperform
€132.00M11.7617.44%2.61%4.75%-15.60%
DEDB1
70
Outperform
€48.20B24.8719.07%1.51%14.88%13.32%
DEPUM
66
Neutral
$3.29B16.997.25%2.75%3.22%-28.92%
DEFME
63
Neutral
€13.61B22.114.37%3.10%0.10%27.83%
61
Neutral
€5.86B12.16-11.12%4.18%3.79%-34.20%
DEBAS
56
Neutral
€37.50B97.612.02%5.35%-0.77%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:BST
Bastei Luebbe
10.10
2.20
27.80%
DE:FME
Fresenius Medical Care AG & Co. KGaA
46.59
11.30
32.01%
DE:BAS
BASF SE
42.53
0.67
1.60%
DE:PUM
PUMA SE NPV
22.16
-20.66
-48.25%
DE:DB1
Deutsche Boerse
263.60
79.55
43.22%
DE:VOW3
Volkswagen
90.32
-8.75
-8.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 08, 2025